SecBot SecBot
SECBOTREPLAY Home › Report › STOK

STOK · A single insider sale occurred at Stoke Therapeutics, with Director…

Stoke Therapeutics, Inc. · CLUSTER filed Mar 9, 2026 at 20:00 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Mar 9, 2026 at 20:00 ET

A single insider sale occurred at Stoke Therapeutics, with Director Arthur A. Levin selling 605 shares for $22,264 in the past week. This transaction is part of a broader pattern of recent insider selling, with four sales totaling $1.8 million over the last 30 days. The activity represents minimal economic impact relative to the company's $1.9B market cap.

  • Director Arthur A. Levin sold 605 shares at $36.80 per share for a total of $22,264
  • Transaction was an open-market sale (Form 4 code 'S')
  • Part of a cluster of 4 insider sales totaling $1.8M over the past 30 days
  • Total recent insider selling ($1.8M) represents only 0.09% of the company's $1.9B market cap

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access